Answer
It is licensed for ALK-positive or ROS1-positive advanced non-small cell lung cancer in adults and specified ALK-positive anaplastic large cell lymphoma and inflammatory myofibroblastic tumours in children and adolescents.
Sources for this answer
- Xalkori 200mg hard capsule — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.